Emily Mullin is a staff writer at Wired covering biotechnology, neurotechnology, and health innovation. Her work bridges scientific advancements and societal impact, with a focus on ethical dilemmas and equity. Based in Pittsburgh, she has contributed to The Washington Post, Scientific American, and Smithsonian Magazine.
Mullin’s career began at the Pittsburgh Post-Gazette, where she honed her skills in investigative health reporting. She later transitioned to national outlets, including MIT Technology Review and Medium’s OneZero, before joining Wired. Her early work focused on medical innovations, but she gradually shifted toward emerging biotechnologies, earning recognition for her coverage of CRISPR, organ transplantation ethics, and the societal implications of neurotech.
While specific article URLs are unavailable in the provided sources, Mullin’s portfolio at Wired emphasizes groundbreaking stories such as the ethical debates around gene-edited embryos and the rise of GLP-1 agonists for obesity treatment. Her reporting often highlights underrepresented voices in science, including researchers advocating for equitable access to biotech innovations.
Mullin prioritizes stories that explore the societal consequences of technologies like CRISPR and synthetic biology. Pitches should address regulatory challenges, equity in access, or long-term environmental impacts. For example, her coverage of xenotransplantation (cross-species organ transplants) underscores her interest in ethical dilemmas, making this a high-priority angle.
She frequently covers collaborations between academia, startups, and policymakers. Successful pitches might involve neurotech startups partnering with ethicists or climate-focused synthetic biology projects. Avoid incremental advancements in favor of transformative, interdisciplinary work.
Mullin’s articles often center on how technologies affect marginalized communities. Proposals should integrate testimonials from patients participating in clinical trials or communities impacted by biotech industries. This approach aligns with her award-winning work on healthcare disparities.
Mullin’s research on cross-species organ transplantation during this fellowship positioned her as a leading voice in bioethics. The fellowship, awarded to journalists addressing critical scientific issues, reflects her ability to translate niche research into public-facing narratives.
This accolade highlights her excellence in science communication, particularly her ability to distill complex topics like mRNA vaccine development into relatable stories during the COVID-19 pandemic.
At PressContact, we aim to help you discover the most relevant journalists for your PR efforts. If you're looking to pitch to more journalists who write on Science, here are some other real estate journalist profiles you may find relevant:
